Niccolò Siliquini

13PUBLICATIONS
13CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Immunogenetics (incl. genetic immunology)Regenerative medicine (incl. stem cells)Pharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Apr 28, 2023
Efficacy of anti-IL-23 and anti-IL-17 after adalimumab failure in psoriatic patients.

L Mastorino, S Susca, C Cariti

|Jun 28, 2022
Guselkumab shows high efficacy and maintenance in the improvement of response until week 48, a real-life study.

Luca Mastorino, Niccolò Siliquini, Gianluca Avallone

|Feb 14, 2022
Risankizumab shows high efficacy and maintenance in improvement of response until week 52.

Luca Mastorino, Sara Susca, Matteo Megna

|Jul 28, 2021
Efficacy, safety, and drug survival of IL-23, IL-17, and TNF-alpha inhibitors for psoriasis treatment: a retrospective study.

Paolo Dapavo, Niccolò Siliquini, Luca Mastorino

Pageof 3

Frequent Collaborators

13 joint publications

Simone Ribero

8 joint publications

Luca Mastorino

7 joint publications

Pietro Quaglino

4 joint publications

Maria Teresa Giura